Osteonecrosis of the jaw flag

Add the patient's medications. ClinDose lists every FDA label statement on osteonecrosis of the jaw (ONJ) and the dental care around it for each drug, and says when a label's codified facts are silent.

Add one or more medications to review their FDA label statements.

Drugs whose labels state an ONJ risk

From the codified FDA label facts in ClinDose (15 products): Alendronate, Alendronate and cholecalciferol, Cabozantinib, Denosumab, Denosumab (Xgeva), Ibandronate, Ibandronate intravenous, Pamidronate, Risedronate, Risedronate and risedronate sodium hemipentahydrate, Risedronate sodium hemi-pentahydrate, Romosozumab, Sunitinib, Vandetanib, Zoledronic acid. Other drugs may carry ONJ statements in label text not yet codified.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.